Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)

This publication has 8 references indexed in Scilit:

• Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
  Clinical Microbiology and Infection, 2021
• Potential remdesivir‐related transient bradycardia in patients with coronavirus disease 2019 (COVID‐19)
  Journal of Medical Virology, 2021
• Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review
  Journal of Cardiovascular Development and Disease, 2021
• Marked Sinus Bradycardia Associated With Remdesivir in COVID-19
  JACC: Case Reports, 2020
• Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approach
  International Journal of Infectious Diseases, 2020
• Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19
  European Journal of Clinical Pharmacology, 2020
• Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia
  Journal of Infection, 2020
• Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study
  Infectious Diseases, 2020